Endo’s Opioid Tab Could Hit $3 Billion Based on Tennessee Deal
Endo International Plc’s $35 million settlement of a multi-billion-dollar Tennessee opioid lawsuit spares the drugmaker a potentially disastrous blow but leaves other threats to the company in place and shows how the larger legal fight is evolving, Bloomberg News reported. The agreement in principle announced Thursday — one day after the mammoth deal that Johnson & Johnson and three drug distributors struck with U.S. state and local governments — requires more than two dozen local governments to sign off. Cash-poor Endo “could have headed for Chapter 11” bankruptcy proceedings if the $2.4 billion Tennessee suit had succeeded, said Richard Ausness, a University of Kentucky law professor who has been following the U.S. opioid litigation. “If the counties are willing to let them settle for $35 million, the Endo guys should take that and run,” he said. “It will let them live to fight another day.” But even if it seals the deal, Endo has many more lawsuits to work through. The pact is for local governments from only three of at least 15 of the state’s judicial districts in which suits have been filed against the company. Meanwhile, Endo is among the defendants in a lawsuit by New York counties seeking more than $2 billion.